Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, suggests a way forward: suppressing a protein called ZNF638 triggers an antiviral immune response...
.png)
4990 Ash Street, Dallas, Texas 75207 972-815-7120
972-815-7120
admin@finhub.com
Copyright © 2024 finance. All Rights Reserved
